Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kirill E. Kopylov"'
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 37:2049-2060
Doramapimod (BIRB-796) is widely recognized as one of the most potent and selective type II inhibitors of human p38α mitogen-activated protein kinase (MAPK); however, the understanding of its binding mechanism remains incomplete. Previous studies in
Autor:
Kirill E. Kopylov, D. A. Pichugina, Vladimir Krotov, A.V. Oleynichenko, Oxana N. Ryzhova, N. E. Kuz’menko, Nadezhda N. Nikitina
Publikováno v:
Supercomputing Frontiers and Innovations. 5
High-level procedures (MP2, CCSD, CCSD(T)) and reliable experimental data have been used to assess the performance of a variety of exchange-correlation functionals for the calculation of structures and energies of small models of thiolate-protected g
Autor:
Vl.V. Voevodin, Kirill E. Kopylov, Maksim V. Shegay, Dmitry A. Suplatov, Nina N. Popova, Vytas K. Švedas
Publikováno v:
Bulletin of the South Ural State University. Series "Computational Mathematics and Software Engineering". 6
Суплатов Дмитрий Андреевич, к.х.н., с.н.с. НИИ физико-химической биологии имени А.Н. Белозерского, Московский государственный университет
Publikováno v:
Bioinformatics (Oxford, England). 34(9)
Motivation Comparative analysis of homologous proteins in a functionally diverse superfamily is a valuable tool at studying structure-function relationship, but represents a methodological challenge. Results The Mustguseal web-server can automaticall
Publikováno v:
Journal of Bioinformatics and Computational Biology. 16:1840005
The visualCMAT web-server was designed to assist experimental research in the fields of protein/enzyme biochemistry, protein engineering, and drug discovery by providing an intuitive and easy-to-use interface to the analysis of correlated mutations/c
Publikováno v:
Talanta. 125
Efforts to replace native peroxidase with its low molecular weight alternatives have stimulated a search for peroxidase mimetics. Herein we describe the oxidation of luminol with hydrogen peroxide catalyzed by commercially available Fe(III)-TAML acti